跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUMIGAN bimatoprost 300 micrograms/mL eye drops bottle - TGA Drug Approval Details
Approvals
/
TGA
/
LUMIGAN bimatoprost 300 micrograms/mL eye drops bottle
Approved
STANDARD
LUMIGAN bimatoprost 300 micrograms/mL eye drops bottle
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
4aeec5fb3d2d405c
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
4aeec5fb3d2d405c
Product Name
LUMIGAN bimatoprost 300 micrograms/mL eye drops bottle
Artg Id
80657
Artg Name
LUMIGAN bimatoprost 300 micrograms/mL eye drops bottle
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2002-09-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8a6a1066012cad2c603dd0e7b6b8814d.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/01a83a7f0f4f4ae928c8256501c94883.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
4aeec5fb3d2d405c
Type
Standard
Back to TGA Approvals
